Hanno Wolfram Livres

The book Key Account Management in Pharma is powered by more than 45 years of experience in the pharmaceutical industry. Writing was driven by the will to add value to marketeers and managers in this great industry around the world. It might be a good point in time and a valuable idea to develop the traditional pharma business-model further. It is about introducing ways to the change from selling drugs to actively contribute to better healthcare. There is no other place, storing more knowledge and expertise around specific diseases, than the pharmaceutical industry itself. This know-how is waiting to be shared. Key Account Management means cross-functional collaboration. KAM helps to surmount and overcome traditional walls of separation inside the industry. Key Account Management paves the way for cooperation and co-creation of solutions between the relevant industries. In support of constantly striving for better healthcare. In a globalized world, with universal access to information, little variations of markets determined by political will and the design of healthcare delivery are getting less important. Many HCPs are waiting for pharma to play a more active role in the delivery of healthcare. Pharma needs to share their wealth of expertise. KAM is about a lot more than pills. This textbook truly is unique. It is the only textbook about this subject.

The primary focus of this book is to enhance patient outcomes through digital transformation in healthcare. After two years of research and writing, it explores how digital advancements can significantly improve various aspects of healthcare and patient lives. The book highlights not only well-known applications but also innovative use cases that illustrate the integration of digital technology in health. While some healthcare stakeholders may view cross-sector collaboration as a threat to their business models, embracing digital necessitates stepping outside traditional comfort zones. The text discusses the digital landscape's past and present, offering insights into existing digital business models and concepts. It emphasizes that healthcare is lagging behind other sectors in adopting digital solutions. The mindset of key players is crucial for advancing digital initiatives, as technology alone is not sufficient. Today, digital is an integral part of everyday life, and its absence would disrupt our current way of living. The book aims to facilitate the adoption of digital ideas to continually improve patient outcomes. The coauthors, each contributing unique perspectives from their professional experiences in India, Germany, and the United States, collectively advocate for better healthcare through collaboration and innovation.

Die Pharmaindustrie wird in diesem Buch umfassend analysiert, wobei sowohl die wirtschaftlichen als auch die ethischen Aspekte beleuchtet werden. Die Autor*innen decken auf, wie Forschung, Entwicklung und Vermarktung von Medikamenten ablaufen und welche Rolle große Konzerne dabei spielen. Zudem wird die Beziehung zwischen Gesundheitspolitik, Patienteninteressen und Profitmaximierung kritisch hinterfragt. Das Werk bietet einen tiefen Einblick in die Herausforderungen und Kontroversen, die die Branche prägen, und regt zur Diskussion über notwendige Reformen an.